JPWO2022051583A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022051583A5
JPWO2022051583A5 JP2023515095A JP2023515095A JPWO2022051583A5 JP WO2022051583 A5 JPWO2022051583 A5 JP WO2022051583A5 JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023515095 A JP2023515095 A JP 2023515095A JP WO2022051583 A5 JPWO2022051583 A5 JP WO2022051583A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
alkenyl
compound according
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023515095A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540350A5 (https=
JP2023540350A (ja
JP7811578B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/049003 external-priority patent/WO2022051583A1/en
Publication of JP2023540350A publication Critical patent/JP2023540350A/ja
Publication of JPWO2022051583A5 publication Critical patent/JPWO2022051583A5/ja
Publication of JP2023540350A5 publication Critical patent/JP2023540350A5/ja
Application granted granted Critical
Publication of JP7811578B2 publication Critical patent/JP7811578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023515095A 2020-09-03 2021-09-03 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用 Active JP7811578B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063074220P 2020-09-03 2020-09-03
US63/074,220 2020-09-03
PCT/US2021/049003 WO2022051583A1 (en) 2020-09-03 2021-09-03 Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists

Publications (4)

Publication Number Publication Date
JP2023540350A JP2023540350A (ja) 2023-09-22
JPWO2022051583A5 true JPWO2022051583A5 (https=) 2024-10-02
JP2023540350A5 JP2023540350A5 (https=) 2024-10-02
JP7811578B2 JP7811578B2 (ja) 2026-02-05

Family

ID=78078371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023515095A Active JP7811578B2 (ja) 2020-09-03 2021-09-03 中環状または大環状ベンジル置換複素環誘導体およびオレキシン-2受容体アゴニストとしてのそれらの使用

Country Status (6)

Country Link
US (1) US20230331720A1 (https=)
EP (1) EP4208465A1 (https=)
JP (1) JP7811578B2 (https=)
CN (1) CN116635393A (https=)
TW (1) TW202227433A (https=)
WO (1) WO2022051583A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4065585B1 (en) 2019-11-25 2025-08-20 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
CN116583502A (zh) 2020-09-03 2023-08-11 欧瑞夏治疗有限公司 二环-杂环衍生物及其作为食欲素-2受体激动剂的用途
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
AU2022280804A1 (en) * 2021-05-26 2023-11-30 Alkermes, Inc. Substituted carbamate macrocyclic compounds and related methods of treatment
JP2025507852A (ja) * 2022-03-01 2025-03-21 センテッサ ファーマシューティカルズ (ユーケー) リミテッド 中環状または大環状ベンジル置換複素環誘導体および関連の使用
IL316468A (en) * 2022-04-22 2024-12-01 Teijin Pharma Ltd The aftermath of oxazepine
CN114716319B (zh) * 2022-04-28 2024-03-26 浙江工业大学 一种联芳氧基烯酸酯类化合物的合成方法
WO2024075825A1 (ja) * 2022-10-07 2024-04-11 キッセイ薬品工業株式会社 シクロペンタン化合物
EP4611745A1 (en) 2022-10-31 2025-09-10 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists
PE20252742A1 (es) 2023-03-16 2025-12-05 Takeda Pharmaceuticals Co Compuestos heterociclicos macrociclicos y sus usos
IL324946A (en) 2023-06-01 2026-01-01 H Lundbeck As Spiro-macrocyclic orexin 2 receptor agonists
EP4719397A1 (en) 2023-06-02 2026-04-08 Takeda Pharmaceutical Company Limited Use of an orexin 2 receptor agonist for improving respiratory function during sleep
TW202535890A (zh) * 2023-10-20 2025-09-16 日商帝人製藥股份有限公司 氧氮呯衍生物之結晶或其溶劑合物之結晶
WO2025124698A1 (en) 2023-12-12 2025-06-19 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
TW202542165A (zh) 2023-12-19 2025-11-01 瑞士商愛杜西亞製藥有限公司 大環食慾素激動劑
WO2025229493A1 (en) 2024-04-29 2025-11-06 Takeda Pharmaceutical Company Limited Dosing of orexin type 2 receptor agonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
PE20081229A1 (es) * 2006-12-01 2008-08-28 Merck & Co Inc Antagonistas de receptor de orexina de diazepam sustituido
US10428023B2 (en) 2017-08-03 2019-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
JP7253640B2 (ja) * 2019-01-31 2023-04-06 武田薬品工業株式会社 複素環化合物およびその用途
EP4065585B1 (en) * 2019-11-25 2025-08-20 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment

Similar Documents

Publication Publication Date Title
JPWO2022051583A5 (https=)
ES2660831T3 (es) Derivados de imidazol condensados útiles como inhibidores de IDO
KR102304111B1 (ko) 베타-클로로시클로펜탄의 친수성 에스테르 전구약물의 이용에 의한 감소된 중심 각막 비후
US12383528B2 (en) Cromolyn esters and uses thereof
JP2009526831A5 (https=)
JP2009530248A5 (https=)
JP2018502891A5 (https=)
JPH07504201A (ja) 環式ampホスホジエステラーゼ及び腫瘍壊死因子の阻害剤としての1−アルコキシ−(2−アルコキシ−またはシクロアルコキシ)−4−(シクロチオアルキル−またはシクロチオアルケニル)ベンゼン
JPH05320142A (ja) 中枢神経系に薬理活性をもつ化合物
JPWO2022051596A5 (https=)
JPWO2019140272A5 (https=)
JP2008542365A5 (https=)
RU2019111188A (ru) Кетоновые ингибиторы лизин-специфичного гингипаина
JPWO2021188778A5 (https=)
CA2598595C (en) Cycloalkylcarboxyl derivatives that stimulate glucose utilization and method of use
AU2015259752B2 (en) Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
US9090595B2 (en) Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
JPWO2022254362A5 (https=)
WO2006027454A1 (fr) Nouveaux derives du 3,5-seco-4-nor-cholestane et leurs utilisations
JPH05503705A (ja) 5―酸素化―2,4,6―トリアミノピリミジン類
JPWO2004063167A1 (ja) 血液脳関門破綻抑制剤
AU2015327817B2 (en) Ester prodrugs of gamma-lactams and their use
CA2271026C (en) 3-amino-propoxyphenyl derivatives
JPWO2022026285A5 (https=)
JPWO2023076218A5 (https=)